7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine

C85H85N33O11S5 — CID 158724577

IUPAC7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine
SMILESCN1CCN(c2cc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)ccn2)CC1.CS(=O)(=O)c1cccc(-c2ccc(-n3cccn3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(CCCN3CCOCC3)nc2)c1-c1nn[nH]n1.Cc1cc2nccn2cc1-c1cccc(S(C)(=O)=O)c1-c1nn[nH]n1.Cc1nnc2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn12
InChIInChI=1S/C20H24N6O3S.C18H21N7O2S.C16H13N7O2S.C16H14N6O2S.C15H13N7O2S/c1-30(27,28)18-6-2-5-17(19(18)20-22-24-25-23-20)15-7-8-16(21-14-15)4-3-9-26-10-12-29-13-11-26;1-24-8-10-25(11-9-24)16-12-13(6-7-19-16)14-4-3-5-15(28(2,26)27)17(14)18-20-22-23-21-18;1-26(24,25)13-5-2-4-12(15(13)16-19-21-22-20-16)11-6-7-14(17-10-11)23-9-3-8-18-23;1-10-8-14-17-6-7-22(14)9-12(10)11-4-3-5-13(25(2,23)24)15(11)16-18-20-21-19-16;1-9-16-17-13-7-6-10(8-22(9)13)11-4-3-5-12(25(2,23)24)14(11)15-18-20-21-19-15/h2,5-8,14H,3-4,9-13H2,1H3,(H,22,23,24,25);3-7,12H,8-11H2,1-2H3,(H,20,21,22,23);2-10H,1H3,(H,19,20,21,22);3-9H,1-2H3,(H,18,19,20,21);3-8H,1-2H3,(H,18,19,20,21)
InChIKeyIKIJJLFNFJIUQZ-UHFFFAOYSA-N
MW1905.17 g/mol
LogP7.38
Rot. Bonds21

About 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine

7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine (PubChem CID 158724577) has the molecular formula C85H85N33O11S5 and a molecular weight of 1905.17 g/mol. Its IUPAC name is 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine.

Molecular Properties

Compound Name7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine
PubChem CID158724577
Molecular FormulaC85H85N33O11S5
Molecular Weight1905.17 g/mol
Exact Mass1903.57
IUPAC Name7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine
SMILESCN1CCN(c2cc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)ccn2)CC1.CS(=O)(=O)c1cccc(-c2ccc(-n3cccn3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(CCCN3CCOCC3)nc2)c1-c1nn[nH]n1.Cc1cc2nccn2cc1-c1cccc(S(C)(=O)=O)c1-c1nn[nH]n1.Cc1nnc2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn12
InChIInChI=1S/C20H24N6O3S.C18H21N7O2S.C16H13N7O2S.C16H14N6O2S.C15H13N7O2S/c1-30(27,28)18-6-2-5-17(19(18)20-22-24-25-23-20)15-7-8-16(21-14-15)4-3-9-26-10-12-29-13-11-26;1-24-8-10-25(11-9-24)16-12-13(6-7-19-16)14-4-3-5-15(28(2,26)27)17(14)18-20-22-23-21-18;1-26(24,25)13-5-2-4-12(15(13)16-19-21-22-20-16)11-6-7-14(17-10-11)23-9-3-8-18-23;1-10-8-14-17-6-7-22(14)9-12(10)11-4-3-5-13(25(2,23)24)15(11)16-18-20-21-19-16;1-9-16-17-13-7-6-10(8-22(9)13)11-4-3-5-12(25(2,23)24)14(11)15-18-20-21-19-15/h2,5-8,14H,3-4,9-13H2,1H3,(H,22,23,24,25);3-7,12H,8-11H2,1-2H3,(H,20,21,22,23);2-10H,1H3,(H,19,20,21,22);3-9H,1-2H3,(H,18,19,20,21);3-8H,1-2H3,(H,18,19,20,21)
InChIKeyIKIJJLFNFJIUQZ-UHFFFAOYSA-N
XLogP7.38
TPSA565.93 Ų
H-Bond Donors5
H-Bond Acceptors39
Rotatable Bonds21
Heavy Atoms134
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001905.17
LogP ≤ 57.38
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1039

Analyze 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine?
The IUPAC name of 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine (CID 158724577) is 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine.
What is the SMILES notation for 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine?
The canonical SMILES for 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine is CN1CCN(c2cc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)ccn2)CC1.CS(=O)(=O)c1cccc(-c2ccc(-n3cccn3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(CCCN3CCOCC3)nc2)c1-c1nn[nH]n1.Cc1cc2nccn2cc1-c1cccc(S(C)(=O)=O)c1-c1nn[nH]n1.Cc1nnc2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn12.
What is the InChIKey of 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine?
The InChIKey is IKIJJLFNFJIUQZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H24N6O3S.C18H21N7O2S.C16H13N7O2S.C16H14N6O2S.C15H13N7O2S/c1-30(27,28)18-6-2-5-17(19(18)20-22-24-25-23-20)15-7-8-16(21-14-15)4-3-9-26-10-12-29-13-11-26;1-24-8-10-25(11-9-24)16-12-13(6-7-19-16)14-4-3-5-15(28(2,26)27)17(14)18-20-22-23-21-18;1-26(24,25)13-5-2-4-12(15(13)16-19-21-22-20-16)11-6-7-14(17-10-11)23-9-3-8-18-23;1-10-8-14-17-6-7-22(14)9-12(10)11-4-3-5-13(25(2,23)24)15(11)16-18-20-21-19-16;1-9-16-17-13-7-6-10(8-22(9)13)11-4-3-5-12(25(2,23)24)14(11)15-18-20-21-19-15/h2,5-8,14H,3-4,9-13H2,1H3,(H,22,23,24,25);3-7,12H,8-11H2,1-2H3,(H,20,21,22,23);2-10H,1H3,(H,19,20,21,22);3-9H,1-2H3,(H,18,19,20,21);3-8H,1-2H3,(H,18,19,20,21).
What are the key properties of 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine?
7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine has a molecular weight of 1905.17 g/mol, XLogP of 7.38, 21 rotatable bonds, 5 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 7-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]imidazo[1,2-a]pyridine;1-methyl-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]piperazine;3-methyl-6-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-[1,2,4]triazolo[4,3-a]pyridine;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyrazol-1-ylpyridine;4-[3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propyl]morpholine is sourced from PubChem (CID 158724577), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).